FeesSafety
Pluang+

FFR completes acquisition of FFAI robotics, aims to lead US robotics education and expand AI robotics ecosystem.

Company Fundamentals
27 Oct 2026, 00:00 WIB
PRNewsWire
View Source
Bullish
FFR completes acquisition of FFAI robotics, aims to lead US robotics education and expand AI robotics ecosystem.

FFR has finalized its acquisition of Faraday Future Intelligent Electric Inc.'s robotics business, integrating it into its Nasdaq-listed operations focused on humanoid and bionic Physical AI robotics. The company appointed new leadership and announced strategic partnerships to expand government and educational market reach. FFR projects sales of about 2,000 robots in 2026 for the acquired business and aims to become the top robotics education provider nationwide and a leading Physical AI robotics company. The company also unveiled its unified AI brain, FF OmniMind, to enhance robotic capabilities across multiple industries.

The FF EAI Robotics Ecosystem's recent acquisition news comes as the Technology sector on Pluang shows broad activity, with 91 of 150 US stocks rising today. Notable movers include DigitalOcean Holdings Inc (DOCN) at USD 100.43 with a 7.73% gain and 100% buy order activity, Celestica Inc (CLS) at USD 279.50 up 7.50% with 98% buy orders, and Credo Technology Group Holding Ltd (CRDO) at USD 157.25 rising 6.76% with a near-even buy/sell split. This snapshot is as of Oct 27, 2026 04:11 WIB.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App